RBC Capital Downgrades Homology Medicines (FIXX) to Sector Perform

February 22, 2022 6:04 AM EST
Get Alerts FIXX Hot Sheet
Price: $1.44 -4%

Rating Summary:
    8 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 24 | New: 19
Join SI Premium – FREE

RBC Capital analyst Luca Issi downgraded Homology Medicines (NASDAQ: FIXX) from Outperform to Sector Perform with a price target of $4.00 (from $30.00).

For an analyst ratings summary and ratings history on Homology Medicines click here. For more ratings news on Homology Medicines click here.

Shares of Homology Medicines closed at $3.86 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades